These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34981713)

  • 21. Soluble HLA antigens and ELISA--a new technology for crossmatch testing.
    Buelow R; Chiang TR; Monteiro F; Cornejo MC; Ellingson L; Claas F; Gaber O; Gelder F; Kotb M; Orosz C
    Transplantation; 1995 Dec; 60(12):1594-9. PubMed ID: 8545896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved flow cytometric detection of donor-specific HLA class II antibodies by heat inactivation.
    Ta M; Scornik JC
    Transplantation; 2002 May; 73(10):1611-4. PubMed ID: 12042648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crossmatching with B and T cells and flow cytometry.
    Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI
    Clin Transpl; 1986; ():277-84. PubMed ID: 3154417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.
    Hart JD; Lutz CT; Jennings CD; May JR; Nelson K; Jacobs S; Hoopes CW
    Transplant Proc; 2015 Apr; 47(3):831-3. PubMed ID: 25891741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches.
    Batal I; Zeevi A; Lunz JG; Aggarwal N; Shapiro R; Randhawa P; Girnita A
    Arch Pathol Lab Med; 2010 Oct; 134(10):1534-40. PubMed ID: 20923311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variable HLA expression on deceased donor lymphocytes: Not all crossmatches are created equal.
    Badders JL; Jones JA; Jeresano ME; Schillinger KP; Jackson AM
    Hum Immunol; 2015 Nov; 76(11):795-800. PubMed ID: 26455297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. For anti-HLA-specific donor antibodies detection by flow cytometry cytotoxic crossmatches comparison of methods.
    Cervelli C; Pisani F; Aureli A; Azzarone R; Scimitarra M; Battistoni C; Di Iulio B; Fracassi D; Scarnecchia MA; Famulari A; Papola F
    Transplant Proc; 2013 Sep; 45(7):2761-4. PubMed ID: 24034042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation with a strongly positive crossmatch: case study and literature review.
    Leonard GR; Shike H; Uemura T; Gaspari JL; Ruggiero FM; Shah RA; Riley TR; Kadry Z
    Liver Transpl; 2013 Sep; 19(9):1001-10. PubMed ID: 23798324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of data-driven models for the flow cytometric crossmatch.
    Weimer ET; Newhall KA
    Hum Immunol; 2019 Dec; 80(12):983-989. PubMed ID: 31530432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
    Alheim M; Paul PK; Hauzenberger DM; Wikström AC
    Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation.
    Visentin J; Guidicelli G; Bachelet T; Jacquelinet C; Audry B; Nong T; Dubois V; Moreau JF; Lee JH; Couzi L; Merville P; Taupin JL
    Transplantation; 2014 Oct; 98(7):738-44. PubMed ID: 25289917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of allele-specific anti-human leukocyte antigen class I antibodies on organ allocation.
    Yeung MY; Murakami N; Kafetzi ML; Simmons DP; Wood I; Macaskill P; Towle M; DellaGatta J; Stevens J; Comeau E; Baronas J; Mohsin N; Chen M; Lee JH; Lane WJ; Milford EL; Guleria I
    Am J Transplant; 2023 Sep; 23(9):1388-1400. PubMed ID: 37257653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
    Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
    Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
    Bray RA; Lebeck LK; Gebel HM
    Transplantation; 1989 Nov; 48(5):834-40. PubMed ID: 2815255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.